Intellia Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2015 | $-1.8M | $-4.3M | $2.6M | $1.3M |
| FY2016 | $36.1M | $29.9M | $6.2M | $6.7M |
| FY2017 | $-65.3M | $-75.4M | $10.1M | $15.3M |
| FY2018 | $-61.3M | $-67.6M | $6.4M | $17.0M |
| FY2019 | $-103.2M | $-110.0M | $6.8M | $15.1M |
| FY2020 | $-49.9M | $-53.5M | $3.6M | $19.9M |
| FY2021 | $-225.0M | $-237.8M | $12.8M | $47.0M |
| FY2022 | $-333.3M | $-346.8M | $13.6M | $91.4M |
| FY2023 | $-394.1M | $-408.1M | $14.0M | $134.1M |
| FY2024 | $-348.9M | $-354.7M | $5.8M | $154.3M |
| FY2025 | $-394.7M | $-395.9M | $1.1M | $80.2M |